| Size & multiples | |||
| Market Cap | $39.63B | Enterprise Value | $40.87B |
| P/E (TTM) | 30.70× | PEG (trailing) | 10.17× |
| P/S | 5.48× | P/FCF | 36.45× |
| EV/EBITDA | 22.31× | EV/EBIT | 26.28× |
| EV/Sales | 5.65× | EV/FCF | 37.60× |
| FCF Yield | 2.74% | Buyback Yield | 0.98% |
| Owner Earnings (TTM) | $1.41B | Owner Earnings Yield | 3.57% |
| Shareholder Yield | 1.70% | ||
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | 1.21 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 10.07% |
| After-tax Cost of Debt | 3.12% | Synthetic credit rating | AAA |
| Cost of Debt · embedded (pre-tax) | 3.44% | Cost of Debt · marginal (synthetic) | 4.40% |
| WACC | 9.57% | ROIC | 97.81% |
| EVA Spread (ROIC−WACC) | 88.24% | EVA | $913.3M |
Synthetic rating = ICR-based credit-quality read (Damodaran), not an agency rating.
Flows TTM (last 4 quarters); latest annual for: EPS (Diluted) · EPS TTM $4.57 · revenue TTM $7.23B · FCF TTM $1.09B
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Rich vs Health Care on P/E, EV/EBITDA
P/E 63rd · EV/EBITDA 73rd percentile in the Health Care pool — placement read per multiple; the API emits no single blended figure, so none is shown.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| P/E | 30.7x | 24.4x | 12.9x–38.8x | 63 ↑rich |
| EV/EBITDA | 23.1x | 15.2x | 9.9x–24.7x | 73 ↑rich |
| FCF Yield | 2.9% | -7.9% | -35.6%–1.4% | 80 ↑strong |
| Dividend Yield | 0.7% | 1.1% | 0.2%–2.4% | 36 ↓weak |
| Net Margin | 18.8% | -21.2% | -325.3%–7.2% | 89 ↑strong |
| Operating Margin | 21.3% | -34.5% | -552.0%–8.0% | 91 ↑strong |
| ROE | 20.6% | -36.8% | -92.5%–4.5% | 90 ↑strong |
